Analystreport

CymaBay Therapeutics, Inc. (NASDAQ: CBAY) had its price target raised by analysts at Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell from $9

CymaBay Therapeutics Inc.  (CBAY) 
Last cymabay therapeutics inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cymabay.com